Abstract

Review Article

Rhabdomyoblasts in Pediatric Tumors: A Review with Emphasis on their Diagnostic Utility

Giuseppe Angelico*, Eliana Piombino, Giuseppe Broggi, Fabio Motta and Saveria Spadola

Published: 09 March, 2017 | Volume 1 - Issue 1 | Pages: 008-016

Rhabdomyosarcoma is a soft tissue pediatric sarcoma composed of cells which show morphological, immunohistochemical and ultrastructural evidence of skeletal muscle differentiation. To date four major subtypes have been recognized: embryonal, alveolar, spindle cell/sclerosing and pleomorphic. All these subtypes are defined, at least in part, by the presence of rhabdomyoblasts, i.e. cells with variable shape, densely eosinophilic cytoplasm with occasional cytoplasmic cross-striations and eccentric round nuclei. It must be remembered, however, that several benign and malignant pediatric tumours other than rhabdomyosarcoma may exhibit rhabdomyoblaststic and skeletal muscle differentiation. This review focuses on the most common malignant pediatric neoplasm that may exhibit rhabdomyoblastic differentiation, with an emphasis on the most important clinicopathological and differential diagnostic considerations.

Read Full Article HTML DOI: 10.29328/journal.jsctt.1001002 Cite this Article Read Full Article PDF

Keywords:

Rhabdomyosarcoma; Nephroblastoma; Malignant triton tumor; Pleuropulmonary blastoma; Rhabdomyoblast

References

  1. Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013; 20: 387-397. Ref.: https://goo.gl/sUAFuX
  2. Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006; 130: 1454-1465. Ref.: https://goo.gl/S8vwk7
  3. Miettinen M, Fetsch JF, Antonescu CR. Tumors with skeletal muscle differentiation. AFIP atlas of tumor pathology: tumors of the soft tissues. Silver Spring: ARP Press. 2014; 289-308.
  4. Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Semin Diagn Pathol. 1994; 11: 69-81. Ref.: https://goo.gl/rg8lUB
  5. Fletcher CDM. Spindle cell/sclerosing rhabdomyosarcoma. World Health Organization (WHO) classification of tumours of soft tissue and bone. Vol 5. Fourth Edn. IARC press: France, Lyon, 2013; 468.
  6. Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol. 1998; 1: 550-61. Ref.: https://goo.gl/PS6z00
  7. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, et al. Spindle cellrhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992; 16: 229-235. Ref.: https://goo.gl/UzGfAW
  8. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002; 26: 1175-1183. Ref.: https://goo.gl/4ipwjA
  9. Rekhi B, Upadhyay P, Ramteke MP, Dutt A. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Mod Pathol. 2016; 29: 1532-1540. Ref.: https://goo.gl/be0R7M
  10. Mungan S, Arslan S, Küçüktülü E, Ersöz Ş, Çobanoğlu B. Pleomorphic Rhabdomyosarcoma Arising from True Vocal Fold of Larynx: Report of a Rare Case and Literature Review. Case Rep Otolaryngol. 2016; 2016: 8135967. Ref.: https://goo.gl/6E9E7H
  11. Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, et al. Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol. 2014; 38: 654-659. Ref.: https://goo.gl/44GfNS
  12. Miki H, Kobayashi S, Kushida Y, Sasaki M, Haba R, et al. A case of infantile rhabdomyofibrosarcoma with immunohistochemical, electronmicroscopical, and genetic analyses. Hum Pathol. 1999; 30: 1519-1522. Ref.: https://goo.gl/XrNi6K
  13. Lundgren L, Angervall L, Stenman G, Kindblom LG. Infantile rhabdomyofibrosarcoma: a high-grade sarcoma distinguishable from infantile fibrosarcoma and rhabdomyosarcoma. Hum Pathol. 1993; 24: 785-795. Ref.: https://goo.gl/KmOrQD
  14. Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med. 2006, 130: 1878-1881. Ref.: https://goo.gl/8BLODr
  15. Durbin AD, Ki DH, He S, Look AT. Malignant Peripheral Nerve Sheath Tumors. Adv Exp Med Biol. 2016; 916: 495-530. Ref.: https://goo.gl/n8eirv
  16. Masson P. Recklinghausen’s neurofibromatosis, sensory neuromas and motor neuromas. In: Libman Anniversary. Vol 2. New York, NY: International Press. 1932: 793-802.
  17. Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant triton tumor. Semin Diagn Pathol. 1994; 11: 69-81. Ref.: https://goo.gl/rTiRHj
  18. Karcioglu Z, Someren A, Mathes SJ. Ectomesenchymoma. A malignant tumor of migratory neural crest (ectomesenchyme) remnants showing ganglionic, schwannian, melanocytic and rhabdomyoblastic differentiation. Cancer. 1977; 39: 2486-2496. Ref.: https://goo.gl/dR4vdr
  19. Huang SC, Alaggio R, Sung YS, Chen CL, Zhang L, et al. Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities with Embryonal Rhabdomyosarcoma. Am J Surg Pathol. 2016; 40: 876-885. Ref.: https://goo.gl/cbhfNV
  20. Chau YY, Hastie ND. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends Genet. 2012; 28: 515-524. Ref.: https://goo.gl/gBcxA1
  21. Salvatorelli L, Parenti R, Leone G, Musumeci G, Vasquez E, et al. Wilms tumor 1 (WT1) protein: Diagnostic utility in pediatric tumors. Acta Histochem. 2015; 117: 367-378. Ref.: https://goo.gl/Cy7A8U
  22. Tu BW, Ye WJ, Li YH. Botryoid Wilms' tumor: report of two cases. World J Pediatr. 2011; 7: 274-276. Ref.: https://goo.gl/enFS3P
  23. Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, et al. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002; 15: 1080-1086. Ref.: https://goo.gl/JH5dM6
  24. Pollono D, Drut R, Tomarchio S, Fontana A, Ibañez O. Fetal rhabdomyomatous nephroblastoma: report of 14 cases confirming chemotherapy resistance. J Pediatr Hematol Oncol. 2003; 25: 640-643. Ref.: https://goo.gl/NKaglc
  25. Irtan S, Ehrlich PF, Pritchard-Jones K. Wilms tumor: "State-of-the-art" update, 2016. Semin Pediatr Surg. 2016; 25: 250-256. Ref.: https://goo.gl/nKgxCA
  26. Cone EB, Dalton SS, Van Noord M, Tracy ET, Rice HE, et al. Biomarkers for Wilms Tumor: A Systematic Review. J Urol. 2016; 196: 1530-1535. Ref.: https://goo.gl/8XxcXX
  27. Fosdal MB. Pleuropulmonary blastoma. J Pediatr Oncol Nurs. 2008; 25: 295-302. Ref.: https://goo.gl/AFy4I5
  28. Mehraein Y, Schmid I, Eggert M, Kohlhase J, Steinlein OK. DICER1 syndrome can mimic different genetic tumor predispositions. Cancer Lett. 2016; 370: 275-278. Ref.: https://goo.gl/rFlSyv
  29. Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, et al. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008; 32: 282-295. Ref.: https://goo.gl/W3ANsO
  30. Sciot R, Dal Cin P, Brock P, Moerman P, Van Damme B, et al. Pleuropulmonary blastoma (pulmonary blastoma of childhood): genetic link with other embryonal malignancies? Histopathology. 1994; 24: 559-563. Ref.: https://goo.gl/XjHWbI
  31. Indolfi P, Bisogno G, Casale F, Cecchetto G, De Salvo G, et al. Prognostic factors in pleuro-pulmonary blastoma. Pediatr Blood Cancer. 2007; 48: 318-23. Ref.: https://goo.gl/1HwiOh

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?